ArticleThe Journal of infectious diseases2026
Hidden Infections, Emerging Resistance: Underdiagnosed Plasmodium vivax and Multidrug Resistance-1 (pvmdr1) Gene Amplification in the Guiana Shield.
Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundPlasmodium vivax is the most widespread malaria parasite, and its cocirculation with Plasmodium falciparum often leads to underdiagnosis and underestimated transmission. We investigated whether underdiagnosis contributes to the selection and spread of drug-resistant parasites in coendemic areas of the Brazilian Amazon.
methodsWe enrolled 727 confirmed malaria cases from three Brazilian states, primarily from Roraima in the Guiana Shield, a region characterized by cocirculation of P. vivax and P. falciparum, intense cross-border mobility, illegal mining activities, and informal antimalarial drug use. To examine indirect P. vivax exposure to antimalarial targeting P. falciparum, we evaluated pvmdr1 copy number variation (CNV).
resultsIn Roraima, molecular diagnosis revealed frequent misclassification of mixed infections, with P. vivax often missed by microscopy due to higher P. falciparum densities, demonstrating the limitations of microscopy in accurately detecting mixed infections. The pvmdr1 CNV exhibited significant geographic variation. While nearly all isolates from the western Amazon carried a single copy, pvmdr1 amplification was detected in 60% of Roraima isolates. In addition to this spatial heterogeneity, temporal analysis revealed significant shifts in amplification patterns over the years, rising to over 70% after 2020.
conclusionsThese findings emphasize the critical importance of accurate diagnosis and rational use of antimalarials, as inadequate or unintended drug exposure may inadvertently drive the selection and spread of parasite strains with reduced drug susceptibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.